Biocon Ltd (BIOCON) Share Price Target Tomorrow| Prediction | Forecast for Intraday

loading widget to trade RELIGARE

The last closing price of BIOCON is 290.95 at 30-Sep-22 3:30:00 PM. We are providing BIOCON share price target on Intraday basis. These levels and targets calculated on the last 15mins candle. Current Support of BIOCON is 288 and Resistance is 292.2 on 15mins basis.

Live BIOCON share price target And Buy/Sell Levels

Last Updated at Last Price Buy Above Short Below
30-Sep-22 3:30:00 PM 290.95 292.2 288

For Intraday purpose:

Buying can be above 292.2 And BIOCON share price target can be 293.95, 295.71, 298.04

Shorting can be below 288 And BIOCON share price target can be 286.27, 284.54, 282.24

Click here for Best Shares to Buy
tomorrow for Intraday trading

This information is only for educational purpose, Please read carefully disclaimer of the website.

There is more information given below of the stock's detailed Technical analysis with the help of all indicators.

Technical Analysis of BIOCON

Last Updated at: 30-Sep-22 9:15:00 AM

Short Moving Average(21 Days)

BIOCON is Bearish on short moving average. Short moving average period is 21 Days.

Medium Moving Average(50 Days)

BIOCON is Bearish on Medium moving average. Medium moving average period is 50 Days.

Long Moving Average(100 Days)

BIOCON is Bearish on Long moving average. Medium moving average period is 100 Days.


BIOCON is Bearish on MACD indicator. MACD Stands for Moving Average Convergence Divergence.It is a trend following momentum indicator. For calculation three moving averages are taken which are 9 day EMA, 12 day EMA & 26 day EMA.


BIOCON is Bearish on Aroon indicator. The Aroon indicator is a technical indicator that is used to identify trend changes in the price of an asset, as well as the strength of that trend. In essence, the indicator measures the time between highs and the time between lows over a time period


BIOCON is Bullish on Stochastic indicator.

Bolinger Band

BIOCON is Neutral on Bolinger Band.
BIOCON Profile
Sector: Health Technology
Industry: Pharmaceuticals: Major
Employees: 12609
Biocon Ltd. is a holding company, which engages in the manufacture, research, and development of therapeutic drugs. It operates through the following segments: Small Molecules, Biologics, Branded Formulations, and Research Services. The Small Molecules segment manufactures spanning statins, immunosuppressants, antifungals, anti-obesity, anti-diabetics, ophthalmologicals, oncologicals, and urologicals etc. The Biologics segment provides Insulins and Analogs, biosimilar Monoclonal Antibodies (MAbs), and recombinant proteins The Branded Formulation segment consists of therapeutic areas of diabetology, oncology, immunology and critical care. The Research Services segment covers Syngene development platforms. The company was founded by Kiran Mazumdar-Shaw on November 29, 1978 and is headquartered in Bangalore, India.